Journal of Drugs in Dermatology

View more issues:

Articles in Feb, 2007 issue of Journal of Drugs in Dermatology

• Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis
  by Adelaide A. Hebert
• Phase II melanoma trial with positive survival data
  by Marissa Heller
• Colloidal oatmeal: history, chemistry and clinical properties
  by Ellen S. Kurtz
• Use of a tongue depressor for eye protection
  by Sareeta R.S. Parker
• Cefprozil for uncomplicated skin and skin-structure infections
  by Marissa Heller
• Photodynamic therapy using silicon phthalocyanine 4 in treating patients with actinic keratosis, Bowen's disease, skin Cancer, or stage I or stage II mycosis fungoides
• Genetic and clinical study of patients with xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy
• Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis
  by Gerald G. Krueger
• Cyclosporine for the treatment of chronic idiopathic urticaria
  by Isaac Brownell
• Study comparing the safety and efficacy of tigecycline with ampicillin-sulbactam or amoxicillin-clavulanate to treat skin infections
• Common allergens in skin tests for adult atopic dermatitis
• Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy
  by James Q. Del Rosso
• Potential foreign body emboli associated with botulinum toxin a injections
  by Kenneth Beer
• Genasense® as a first-line therapy for advanced melanoma
  by Marissa Heller
• Effect of bosentan on skin fibrosis in patients with systemic sclerosis
• Determining the photoadaptation of depigmented skin to targeted phototherapy using UVB in patients with vitiligo
• Searching for a safe and effective therapy for pemphigus vulgaris—the rituximab IVIg combination
  by Isaac Brownell
• Neuroskin Forte for dry skin relief in eczema and psoriasis
• Photodynamic therapy in treating patients with skin cancer
• Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp
  by Emil Tanghetti
• Bexarotene and interferon-[alpha] combination therapy in a patient affected by relapsing anaplastic large cell lymphoma with cutaneous involvement
  by Marco Ardigo
• Phase III study of Nexavar fails to meet primary endpoint
  by Marissa Heller
• Clinical usefulness of optical skin biopsy
• Efficacy and safety study of dermal-living skin replacement to treat diabetic foot ulcers
• Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma
  by Tania Cestari
• Dermoscopy as a tool for rapid diagnosis of monilethrix
  by Adriana Rakowska
• FDA approves CTA for cosmetic augmentation
  by Marissa Heller
• Topical morphine for analgesia in patients with skin grafts
• Comparison of cephalexin versus clindamycin for empiric treatment of suspected CA-MRSA skin infections
• Hydroquinone and the FDA—the debate?
  by Melanie D. Palm
• Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation
  by Michael H. Gold
• Dutasteride for androgenetic alopecia
  by Isaac Brownell
• Computer-based continuing education for doctors in examination and counseling of patients on skin cancer or weight control
• Split-thickness skin graft donor site wound healing study
• Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT
  by Bruce E. Katz
• Skin tightening with a combined unipolar and bipolar radiofrequency device
  by Flor A. Mayoral
• Phase II study of ARYS-01 for herpes zoster
  by Marissa Heller
• Study of cetuximab in squamous cell carcinoma of the skin expressing EGFR
• Sunless tanning products as a substitute for sunbathing in healthy participants
• Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging
  by C. William Hanke
• Palliative treatment of fingernail lichen planus
  by Noel M. Prevost
• FDA Fast Track designation for Ipilimumab for metastatic melanoma
  by Marissa Heller
• Reconstitution with pimecrolimus cream 1% of steroid-damaged skin in adults with atopic dermatitis
• The effects of microdermabrasion on skin remodeling
• Panfacial botulinum toxin improves patient retention
  by Martin Braun
• Osteomyelitis occurring during infliximab treatment of severe psoriasis
  by Jennifer C. Sri
• Expansion of clinical trial Belinostat for Cutaneous T cell Lymphoma
  by Marissa Heller
• The effect of Efudex treatment on photoaged skin
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin